Design of small molecule libraries for NMR screening and other applications in drug discovery

被引:40
|
作者
Jacoby, E [1 ]
Davies, J
Blommers, MJJ
机构
[1] Novartis Pharma AG, Drug Discovery Ctr, Compound Management & Computat Unit, CH-4002 Basel, Switzerland
[2] Novartis Pharma Inc, Drug Discovery Ctr, Compound Management & Computat Unit, Summit, NJ USA
[3] Novartis Pharma AG, Cent Technol, Prot Struct Unit, CH-4002 Basel, Switzerland
关键词
D O I
10.2174/1568026033392606
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
There are conceptual differences between high-throughput screening (HTS) and fragment-based screening by NMR. The number of compounds in libraries for NMR screening may be significantly smaller than those used for HTS. Because one relies on a small library its design is significantly important and is the object of this article. A short introduction on fragment-based NMR screening approaches will be provided. Although there are currently very few reports describing the design of libraries of small molecules for NMR screening, aspects of the question of how to compile diverse collections of small molecular fragments useful for drug design were previously addressed for the purposes of combinatorial library design and de novo drug design. As these disciplines are highly interrelated and are applied in an interconnected manner with NMR screening within the drug discovery process, a review of combinatorial library design and especially the building block or fragment selection strategies applied for combinatorial library design and de novo design is well suited to reveal fundamental strategies and potential techniques for the design of NMR screening libraries. This section will be rounded off by a report on hands-on-experience with the design of the Novartis second-site NMR screening library and practical considerations for the design of compound mixtures. Rather than providing an exact protocol general guidelines will be indicated.
引用
收藏
页码:11 / 23
页数:13
相关论文
共 50 条
  • [1] Developing small-molecule libraries for drug discovery
    Gravert, DJ
    Janda, KD
    [J]. TRENDS IN BIOTECHNOLOGY, 1996, 14 (04) : 110 - 112
  • [2] NMR screening techniques in drug discovery and drug design
    Stockman, BJ
    Dalvit, C
    [J]. PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2002, 41 (3-4) : 187 - 231
  • [3] The role of NMR in advancing small molecule drug discovery
    Poppe, Leszek
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (04)
  • [4] Applications of NMR SHAPES screening in drug discovery.
    Moore, JM
    Fejzo, J
    Lepre, CA
    Peng, JW
    Abdul-Manan, N
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U38 - U38
  • [5] NMR-based screening in drug discovery and design
    Hajduk, P
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2762 - U2762
  • [6] Hierarchical virtual screening approaches in small molecule drug discovery
    Kumar, Ashutosh
    Zhang, Kam Y. J.
    [J]. METHODS, 2015, 71 : 26 - 37
  • [7] Design of small molecule libraries
    Flagstad, Thomas
    Nielsen, Thomas
    Clausen, Mads
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [8] NMR screening in drug discovery
    Moore, JM
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (01) : 54 - 58
  • [9] Application of solid phase synthesized small molecule libraries in drug discovery.
    Mjalli, AMM
    Toyonaga, BE
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 119 - BIOT
  • [10] Applications of small-molecule combinatorial chemistry to drug discovery
    Patel, DV
    Gordon, EM
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (04) : 134 - 144